New call-to-action
New call-to-action
New call-to-action

Webinar: What You Can Expect if You Participate in TEMPO, a Phase 3 Trial of Pitolisant

Learn more about the PWS Clinical Trial of Pitolisant now enrolling patients ages 6 to 65 years old in this webinar.

If your loved one with PWS struggles with daytime sleepiness, you may be interested in learning more about TEMPO, a phase 3 study of Pitolisant, now enrolling volunteers with PWS ages 6 to 65  years old. This study will evaluate the efficacy of Pitolisant in treating excessive daytime sleepiness in children and adults with PWS, as well as its efficacy in improving irritable and disruptive behaviors, hyperphagia, and other behavioral challenges.

A live webinar was conducted in June 2024,  sharing details of the study, what you can expect if you choose to participate, and eligibility criteria for participation. The presentation is 20 minutes in length, followed by 10 minutes of Q&A. You can watch the complete presentation by clicking on the embedded video. In case you don't have time to watch the full video, we've included slides from the presentation below.

Please visit the TEMPO website for more information on this study.        




Tempo Slide1

Tempo Slide4

Tempo Slide7

Tempo Slide8

Tempo Slide9

Tempo Slide10

Tempo Slide11

Tempo Slide12

Tempo Slide13















Topics: Research

Susan Hedstrom


Susan Hedstrom is the Executive Director for the Foundation for Prader-Willi Research. Passionate about finding treatments for PWS, Susan joined FPWR in 2009 shortly after her son, Jayden, was diagnosed with Prader-Willi Syndrome. Rather than accepting PWS as it has been defined, Susan has chosen to work with a team of pro-active and tireless individuals to accelerate PWS research in order to change the future of PWS. Inspired by her first FPWR conference and the team of researchers that were working to find answers for the syndrome, she joined the FPWR team in 2010 and led the development of the One SMALL Step walk program. Under Susan’s leadership, over $15 million has been raised for PWS related research.